Published June 2014 | Version v1
Journal article

Fibromyalgia Complicating Disease Management in Rheumatoid Arthritis

  • 1. The Indus Hospital, Karachi (Pakistan). Dept. of Medicine
  • 2. Sindh Inst. of Urology and Transplantation, Karachi (Pakistan). Dept. of Medicine

Description

Objective: To evaluate frequency of fibromyalgia in rheumatoid arthritis and its effect on disease activity score. Study Design: Cross-sectional study. Place and Duration of Study: The Indus Hospital, Karachi, from December 2010 to May 2011. Methodology: All adult patients of either gender diagnosed as rheumatoid arthritis on the basis of clinical, laboratory and X-ray criteria were included in the study. The sample data was separated into two groups depending on presence or absence of fibromyalgia and 28 joint disease activity score (DAS-28) value was evaluated. Results: There were 31 (25.83%) patients with rheumatoid arthritis and fibromyalgia (RAFM) out of the total 120. The median (IQR) age of patients was 40 (32 - 51) years. All were females. The overall female frequency was 79 (88.8%). The median (IQR) DAS-28 score in RA group was 4.9 (3.66 - 5.71), while the median (IQR) DAS-28 score in RAFM was 7.04 (6.62 - 7.64) [p < 0.0001]. The number of patient getting combination therapy of DMARD in RAFM group was 61.3% while in RA group was 42.7%. Conclusion: DAS-28 was found to be significantly higher in RAFM patients probably because of higher perception of pain. (author)

Additional details

Publishing Information

Journal Title
JCPSP. Journal of the College of Physicians and Surgeons Pakistan
Journal Volume
24
Journal Issue
6
Journal Page Range
p. 424-427
ISSN
1022-386X

INIS

Country of Publication
Pakistan
Country of Input or Organization
Pakistan
INIS RN
45076036
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ADULTS; BONE JOINTS; COMBINED THERAPY; COMPARATIVE EVALUATIONS; PAIN; RHEUMATIC DISEASES; SKELETAL DISEASES
Descriptors DEC
AGE GROUPS; BODY; DISEASES; EVALUATION; MEDICINE; ORGANS; SKELETON; SYMPTOMS; THERAPY